SHG:688767 - Hangzhou Biotest Biotech Co Ltd Hangzhou Biotest Biotech Co Lt
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance
Balance Sheet Cash Flow Income Statement Key Ratios
Adjust Display Metrics

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2017 Q4 2018 Q4 2019 Q4 2020 Q1 2020 Q2 2020 Q4 2021 Q1 2021 Q2 Graph
Total Assets [friend] - - - 580.41M
-
- 976.22M
-
1.39B
42.5%
Total Liabilities [friend] - - - 180.37M
-
- 300.55M
-
379.01M
26.1%
Total Equity [friend] - - - 400.67M
-
- 677.21M
-
1.01B
49.6%
Operating CashFlow [friend] 21.17M
199.3%
25.67M
21.2%
- - 446.07M
-
- -
Investing CashFlow [friend] -12.61M
-
-39.47M
-
-14.33M
-
-64.38M
-
-56.08M
-
-63.71M
-
-38.94M
-
Financing CashFlow [friend] -1.01M
-
10.94M
-
5.97M
-45.4%
-34.43M
-
-124.92M
-
-148.4M
-
-115.75M
-
Beginning Cash Position [friend] 8.78M
43.7%
16.21M
84.7%
- - 13.68M
-
82.7M
504.4%
244.85M
196.1%
End Cash Position [friend] 16.21M
84.7%
13.68M
-15.6%
82.7M
504.4%
244.85M
196.1%
261.05M
6.6%
541.1M
107.3%
937.24M
73.2%
Free CashFlow [friend] 8.5M
-
-13.81M
-
76.18M
-
231.1M
203.4%
388.38M
68.1%
612.57M
57.7%
757.32M
23.6%
Total Revenue [friend] 180.3M
48.1%
208.84M
15.8%
78.61M
-62.4%
414.84M
427.7%
865.37M
108.6%
1.28B
47.8%
1.53B
19.6%
Net Income (Cont Operations) [friend] 18.85M
461.9%
27.94M
48.2%
- - 434.97M
-
- -
Diluted Net Income [friend] - - - - - - -
Diluted EPS [friend] 0.24
380%
0.35
45.8%
0.449
28.3%
3.332
641.8%
5.44
63.3%
7.905
45.3%
8.77
10.9%
Net Margin [friend] 10.49%
216.8%
13.52%
28.9%
45.71%
238.2%
64.26%
40.6%
50.28%
-21.7%
49.46%
-1.6%
45.85%
-7.3%
Return On Equity [friend] 21.11%
320.3%
25%
18.4%
- 66.53%
-
152.39%
129.1%
93.38%
-38.7%
99.23%
6.3%
Return On Assets [friend] 13.4%
323.9%
15.46%
15.4%
- 45.93%
-
103.07%
124.4%
64.78%
-37.2%
71.15%
9.8%
Values are in CNY whenever applicable | Fiscal year ends on December 31
Powered by Morningstar